Similarly, Donafenib induces oxidative stress in HCC cells by increasing mROS, decreasing GPx activity, and suppressing Mn-SOD, ultimately reducing mitochondrial membrane potential, COX IV activity, and ATP levels [31]. Here, COX4I1 is linked to hepatocellular carcinoma.